TheEdgeResearch
Home / Stocks / LVZPF

Livzon Pharmaceutical Group Inc. (LVZPF)

OTC Healthcare Medical - Pharmaceuticals
$5.22 ▲ +0.00%
Market Cap
$6.06B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.24
52-Wk Range
3.43-5.22
CEO
Daping Liu
Country
CN
Currency
USD

Livzon Pharmaceutical Group Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Zhuhai, GD, CN. The stock last traded at $5.22, up 0.00% on the session, giving a market capitalisation of $6.06B. On trailing twelve-month figures it carries a trailing P/E of 13.78, a net margin of 16.8%. Its beta of 0.24 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
13.78
Price / Sales
2.32
Price / Book
1.87
EV / EBITDA
7.14
Gross margin
65.7%
Operating margin
22.7%
Net margin
16.8%
Return on equity
Debt / equity
0.26
Current ratio
1.96
Dividend yield
4.7%
Payout ratio
85.3%
Company profile
Exchange
Other OTC
Employees
8,878
IPO date
2018-06-29
Headquarters
Zhuhai, GD, CN
About Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc., founded in 1985 and based in Zhuhai, China, is dedicated to the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, active pharmaceutical ingredients (APIs), and related intermediates. The company's diverse range of medications includes Ilaprazole enteric-coated tablets for treating duodenal ulcers and reflux esophagitis, and Laprazole sodium for injection to manage peptic ulcer hemorrhage. It also offers Leuprorelin Acetate Microspheres for injection and Urofollitropin for injection to address anovulation and other fertility concerns. Psychiatric conditions are covered by Perospirone Hydrochloride for schizophrenia, while respiratory ailments benefit from Anti-viral Granules for upper respiratory tract infections and influenza. Furthermore, its traditional Chinese medicine offerings feature Shenqi Fuzheng Injection, used to alleviate general weakness, tiredness, lassitude, spontaneous sweating, and vertigo, and is also beneficial for patients with lung and stomach cancer. Beyond therapeutic drugs, Livzon Pharmaceutical Group also produces a variety of diagnostic reagents. These encompass kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid test kits for human immunodeficiency virus type 1 (HIV-1), antinuclear antibody test kits, interferon-gamma release assays, and rapid tests for Mycoplasma pneumoniae IgM antibodies. The company's comprehensive portfolio extends to biochemical drugs, microbiological preparations, biologics, traditional Chinese drug preparations, pharmaceutical raw materials, and various antibiotics. While its primary operations are within the People's Republic of China, Livzon Pharmaceutical Group also engages in the export of its products internationally.

Comparable companies

Livzon Pharmaceutical Group Inc. is most often compared with the following Healthcare names:

CZMWYDNPUFHKMPFHKMPYHLBBFHLUBFSGFEFSMDPYSNPHFULIHF
More research on LVZPF
LVZPF technical analysis LVZPF TheEdge Score Compare against peers
Open full interactive analysis & DCF →